TC | 
Stat | 
Stk | 
Ins | 
Fil | 
+d | 
+w | 
+m | 
+q | 
+h | 
+y | 
avg | 
				
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 4 | 6 | 6 | 9 | 21 | -1 | -22 | 3 | 
| P | %wins | 100 | 50 | 50 | 100 | 33 | 33 | 61 | 
Filing Date | 
					T Date | 
					Ticker | 
					Issuer | Inc | 					Sector | 
					Ind | Industry |  
						Owner | 
						oSt | 
						Rel | 
						Title | 
					 
					T | 
					TVal | 
					Price | 
					L | 
					Qty | 
					oc | 
					Own | 
					H | 
					r2y | 
					r1y | 
					r6m | 
					r3m | 
					r6w | 
					r3w | 
					r7d | 
					r3d | 
					f1d | 
					f1w | 
					f1m | 
					f3m | 
					f6m | 
					f1y | 
				
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/7/22 17:30  | 6/7/22  | EFTR | Effector Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Byrnes Michael | CA | O | CFO | P | 33 | 1.33 | 0 | 25 | 591 | 29 | D | ||||||||||||||
3/28/17 16:06  | 3/28/17  | OCRX | Ocera Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Byrnes Michael | CA | O | CFO,Trea | P | 4 | 1.28 | 9 | 3 | 30 | 13 | D | -73 | -56 | -51 | -40 | 93 | 115 | -17 | 8 | 2 | -3 | -1 | |||
1/19/16 08:14  | 1/15/16  | OCRX | Ocera Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Byrnes Michael | CA | O | CFO,Trea | P | 7 | 2.07 | 0 | 4 | 54 | 10 | D | -89 | -67 | -54 | -47 | -39 | -41 | -31 | -27 | 8 | 27 | 38 | 44 | 37 | 7 | 
5/6/15 18:03  | 5/6/15  | OCRX | Ocera Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Byrnes Michael | CA | O | CFO,Trea | P | 9 | 3.61 | 0 | 3 | 63 | 7 | D | -41 | -58 | -39 | -43 | -27 | -10 | -8 | 5 | 9 | 10 | 5 | 13 | -7 | -21 | 
10/2/14 16:16  | 10/1/14  | OCRX | Ocera Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Byrnes Michael | CA | O | VP,Finan | P | 10 | 4.81 | 0 | 2 | 100 | 4 | D | -90 | -35 | -48 | -28 | -5 | 1 | 3 | 16 | 4 | -12 | -6 | 6 | -32 | -52 | 
| D | Derivative transaction in filing (usually option exercise) | 
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price | 
| A | Amended filing | 
| E | Error detected in filing | 
| S - Sale | Sale of securities on an exchange or to another person | 
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) | 
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company | 
| P - Purchase | Purchase of securities on an exchange or from another person |